This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Visa, MasterCard: Dog-Day Financial Losers

Stocks in this article: BACCJPMWFCVMA

NEW YORK ( TheStreet) -- Visa (V) and MasterCard (MA) were the financial losers on Monday, with shares of both processors sliding 2%.

Shares of Visa closed at $175.00, while MasterCard closed at $615.18.

The broad indices ended mixed, with the biggest splash of the day being the agreement by Amgen (AMGN) to acquire Onyx Pharmaceuticals (ONXX) for $125 a share, or roughly $10.4 billion in cash. Investors were pleased with the deal, sending Amgen's shares up 8% to close at $113.75, although shares of Onyx were up only 6% to close at $123.49.

Monday's economic calendar was light. The Commerce Department said U.S. durable goods orders declined during July by $17.8 billion, or 7.3%, for their sharpest drop since August 2012. The July decline broke a three-month streak of increases.

The KBW Bank Index (I:BKX) was down 1% to close at 64.38, with 24 index components seeing declines except for M&T Bank of Buffalo (MTB), which was up slightly to close at $118.54.

Shares of JPMorgan Chase (JPM) pulled back 1% to close at $51.80, after Rafferty Capital Markets analyst Richard Bove cut his rating on the bank to "hold" from "buy," while lowering his price target for the shares to $57 from $60.00. Bove cited "clear risks to company earnings as a consequence of the government vendetta" against the company.

According to JPMorgan's second-quarter 10-Q filing, there are six separate investigations by the Department of Justice against the company, along with four investigations by the Securities and Exchange Commission and three by the Commodities Futures Trading Commission.

Despite setting earnings records over the past three years, JPMorgan's headline risk is holding its shares to the lowest valuation among the "big four" U.S. banks, which also include Citigroup (C), Bank of America (BAC) and Wells Fargo (WFC):

  • At Monday's close, JPMorgan's shares traded for 8.5 times the consensus 2014 earnings estimate of $6.11 a share, among analysts polled by Thomson Reuters.
  • Shares of Citigroup closed at $49.60 Monday and traded for 8.9 times the consensus 2014 EPS estimate of $5.57.
  • Bank of America closed at $14.49 and traded for 10.5 times the consensus 2014 EPS estimate of $1.38.
  • Wells Fargo's shares closed at $42.39 and traded for 10.5 times the consensus 2014 EPS estimate of $4.02.

Payment Processors

Visa and MasterCard are both valued highly by the market, because of their stellar track records for growth. Visa's shares trade for 19.7 times the consensus fiscal 2014 EPS estimate of $8.90, while MasterCard trades for 20.1 times the consensus 2014 EPS estimate of $30.68.

The payment processing scene is quite unsettled at the moment, after U.S. district court judge Richard J. Leon in Washington ruled on July 31 that the Federal Reserve had "clearly disregarded Congress's statutory intent by inappropriately inflating all debit card transaction fees by billions of dollars and failing to provide merchants with multiple unaffiliated networks for each debit transaction."

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs